HOME >> BIOLOGY >> NEWS
UCLA cancer researchers shake loose hidden biomarker

Using a common chemotherapy agent, researchers at UCLA's Jonsson Cancer Center and the Department of Pathology and Laboratory Medicine found a way to move an important biomarker expressed in prostate cancer, shaking it loose from one location in a cell where it could not be accessed by blood to another, easier to target area.

The discovery, outlined in the cover article of May 11 edition of the peer-reviewed journal Molecular Cancer Therapeutics, could have important implications for using immunotherapy to treat prostate cancer, said Ayyappan K. Rajasekaran, a Jonsson Cancer Center researcher and senior author of the article.

The method discovered by the research team places the prostate-specific membrane antigen (PSMA) in a location on the cell that would allow blood-borne immunotherapies to access the biomarker, transforming it from a hidden target into an exposed one.

"In prostate cancer cells, PSMA is expressed in the apical region of the cell membrane, which blood can't reach, so injection of immunotherapy into the bloodstream is not effective," said Rajasekaran, also an associate professor of pathology and laboratory medicine. "By using information from very basic studies about how the PSMA protein is targeted in these cells, we identified a way to redirect this protein within the cell. We found that if we disturbed hollow tubular structures called microtubules, part of the cell's framework, we were able to relocate PSMA from its 'hidden' location on the apical membrane to an accessible area in the basolateral surface."

To cause this disturbance and the resulting relocation of PSMA, Rajasekaran and his team employed a commonly used cancer chemotherapy agent, which destroys the microtubules.

"These patients are getting chemotherapy anyway, and once we move the PSMA to a more accessible area on the prostate cancer cell, we might be able to use antibody-based immunotherapies as well, and they could be administered in the blood," he sai
'"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
11-May-2005


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Newly created cancer stem cells could aid breast cancer research
3. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
4. ESF EURYI award winner aims to stop cancer cells reading their own DNA
5. No evidence that widely prescribed statins protect against prostate cancer
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. New study suggests Concord grape juice may provide protection against breast cancer
8. New test improves detection of liver cancer
9. High-intensity ultrasound may launch attack on cancer, wherever it lurks
10. Unknotting DNA clue to cancer syndrome
11. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... OTTAWA, Ontario (PRWEB) , ... November 20, 2018 , ... ... Track-Kit system to track all newborn screening (NBS) specimens across the state. ... shipment from hospitals and delivery to the state newborn screening laboratory in Salt Lake ...
(Date:11/15/2018)... ... November 15, 2018 , ... Superior ... and IT solutions with 140 employees on both the east and west coasts, ... (CSIA) Certification. CSIA Certified control system integrators must pass an intensive audit ...
(Date:11/15/2018)... ... 14, 2018 , ... Researchers from Ambry Genetics (Ambry) ... gene-disease relationships and how it supports medical management decisions at the National Society ... , Ambry has been selected by NSGC to lead a platform presentation ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD ... by Siemens Healthineers and several healthcare VC firms announces at Distributed Health 2018 ... a history by purchasing tokens and obtaining its first radiology interpretations, one of ...
(Date:11/3/2018)... ... November 01, 2018 , ... ... Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA ... and ensure data reliability. , What should clinical research industry stakeholders keep in ...
(Date:10/31/2018)... (PRWEB) , ... October 30, 2018 , ... ... its randomized, controlled trial at the Campbell Clinic in Memphis, Tennessee. This ... system to the standard of care for managing pain after total knee replacement ...
(Date:10/31/2018)... ... October 30, 2018 , ... Today, the National Corn Growers Association (NCGA) announced ... competition is to find new and innovative uses of field corn. NineSigma is serving ... billion bushels of corn and are on pace to produce the second largest crop ...
Breaking Biology Technology:
Cached News: